Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

Next Generation Sequencing Testing (NGS)

NHS Blood and Transplant

This public procurement record has 4 releases in its history.

Award

25 Jun 2026 at 11:30

UK6 - Contract Award Notice
TenderUpdate

26 Jan 2026 at 11:05

UK4 - Tender Notice
Tender

12 Jan 2026 at 08:35

UK4 - Tender Notice
Planning

15 May 2025 at 16:45

UK2 - Preliminary Market Engagement Notice
Summary of the contracting process

The procurement process for the Next Generation Sequencing Testing (NGS) project by NHS Blood and Transplant has been completed. NHS Blood and Transplant, a public authority under central government, has its offices located in Bristol, UK. They were seeking a provider for NGS QC testing services to meet the regulatory requirements of the Cellular and Molecular Therapies directorate. The procurement process utilised an open method known as a Competitive Flexible Procedure, with the award announced on 25 June 2026. The contracting phase was complete, with the contract set to commence on 1 August 2026, ending on 31 July 2027, with a potential 12-month extension. The procurement category was services, specifically in the healthcare and biotechnology sector.

This tender presents substantial business opportunities for firms involved in system quality assurance and review services, particularly those specialising in advanced therapeutic investigational medicinal products and starter material master cell banks. While the contract has been awarded to SGS United Kingdom Limited, the procurement process illustrates the potential for large-scale contracts with public authorities, a beneficial consideration for businesses aiming to expand in the biotechnology and healthcare industries. Companies with the capability to meet stringent regulatory requirements and those with existing EU Good Manufacturing Practice licences would be well-positioned to compete for similar future contracts.

How relevant is this notice?

Notice Information

Notice Title

Next Generation Sequencing Testing (NGS)

Notice Description

NHS Blood and Transplant (NHSBT) are seeking a provider for Next Generation Sequencing (NGS) QC testing requirements for the Cellular and Molecular Therapies (CMT) directorate, namely the Clinical Biotechnology Centre (CBC). CBC handle a number of products in the production of Advanced Therapeutic Investigational Medicinal Products (ATMPs) and starter material master cell banks (MCBs). These require NGS QC testing services that meet specific regulatory requirements.

Lot Information

Lot 1

Options: One (1) year optional extension

Renewal: One (1) year optional extension

Planning Information

Interested suppliers are asked to express their interest to rowena.thomas@nhsbt.nhs.uk and carley.butcher@nhsbt.nhs.uk by 5pm on Friday, 13th June 2025. Suppliers expressing an interest will be invited to attend an early market engagement exercise supplier meeting during the week of the 16th June 2025 (note: date subject to change). Prior to this session, interested suppliers will be provided with a draft specification of requirements and short questionnaire related to requirements. There is no guarantee that a formal procurement process will be launched as a result of this early market engagement exercise, nor that any contract(s) will be placed. No remuneration or compensation etc will be paid to organisations who take part in this early market engagement exercise. Suppliers should take part in this process only on the basis that they fully understand and accept this position.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-0514f8
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/059773-2026
Current Stage
Award
All Stages
Planning, Tender, Award

Procurement Classification

Notice Type
UK6 - Contract Award Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Open
Procurement Method Details
Competitive flexible procedure
Tender Suitability
SME
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

72 - IT services: consulting, software development, Internet and support

CPV Codes

72225000 - System quality assurance assessment and review services

Notice Value(s)

Tender Value
£600,000 £500K-£1M
Lots Value
£600,000 £500K-£1M
Awards Value
£407,200 £100K-£500K
Contracts Value
Not specified

Notice Dates

Publication Date
25 Jun 20262 months ago
Submission Deadline
20 Feb 2026Expired
Future Notice Date
17 Jul 2025Expired
Award Date
24 Jun 20262 months ago
Contract Period
1 Aug 2026 - 31 Jul 2027 6-12 months
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Pending
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS Blood and Transplant
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
BRISTOL
Postcode
BS34 7QH
Postcode Area
Bristol
Country
England
Major Region (ITL 1)
TLK South West (England)
Basic Region (ITL 2)
TLK5 West of England
Small Region (ITL 3)
TLK52 Bath & North East Somerset and South Gloucestershire
Delivery Location
TLK11 Bristol, City of
Local Authority
South Gloucestershire
Electoral Ward
Filton
Westminster Constituency
Filton and Bradley Stoke

Supplier Information

Number of Suppliers
1
Supplier Name

SGS United Kingdom Limited

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...